Company news

Transcenta Holding Limited news in 2025

Transcenta Holding Limited's news releases, calls and decks from 2025, newest first.

Transcenta Therapeutics Announces Strategic Collaboration and Non-exclusive Licensing Agreement to Advance Integrated Continuous Biomanufacturing and Expand Global Access to Affordable Biologics

December 27, 2025

Transcenta Therapeutics Presents Updated Efficacy Data from the Phase I/II Transtar102 Trial of Osemitamab plus Nivolumab and CAPOX in First-Line G/GEJ Cancer at ESMO Asia

December 4, 2025

Decks in 2025

H1 2025 Earnings Presentation
Earnings · 33 slides · Aug 28, 2025
FY2024 Earnings Presentation
Earnings · 27 slides · Mar 31, 2025